The Philadelphia Coalition for a Cure, a new cooperative clinical diagnostics and research initiative, announced a partnership with Children’s Hospital of Orange County in Orange to diagnose and study adult and pediatric brain tumors, and help develop personalized therapy.
The collaboration will use NantHealth Inc.’s GPS Cancer, a scan that combines molecular profiling and diagnostic tests to better inform treatments.
Culver City-based NantHealth has a market cap of about $954.3 million. It is one of the constituent healthcare companies that make up NantWorks Co., which is controlled by Patrick Soon-Shiong. Soon-Shiong is the wealthiest man in Los Angeles, with an estimated net worth of $15.4 billion.
The coalition comprises the division of neurosurgery and the center for data-driven discovery at Children’s Hospital of Philadelphia, Hyundai Cancer Institute at CHOC, three Philadelphia-based universities––University of Pennsylvania, Temple University and Thomas Jefferson University––and Rowan University in New Jersey.
“Brain tumors can occur at any age, and can be found in anyone … this year alone more than 20,000 adults will be newly diagnosed with brain tumors,” said Dr. Jay Storm, chief of the division of neurosurgery at Children’s Hospital of Philadelphia, in a press release. “Together we’re embarking on an incredibly exciting journey toward revolutionizing cancer care.”
The collaboration also includes Philadelphia-based health insurer Independence Blue Cross and Cancer Breakthroughs 2020, a collaborative cancer initiative that aims to find a new standard of care for cancer patients by 2020 via second-phase trials in 20,000 patients.
The collaborators plan to make all patient-consented data accessible to the research community through New York-based Cavatica Inc., a cloud-based data analysis and storage platform developed to allow researchers to access, share and analyze data on several childhood diseases, including pediatric cancers, epilepsy and autism.
Med Tech Monday
Irvine-based Med Tech Directory plans to roll out another Med Tech Monday in August following its first event at the Atrium Hotel in Irvine last month. The directory, announced last July, lists “medical devices, conferences, employment and funding,” according to its website.
“The [medical device] segment, is fragmented,” said Med Tech Directory founder Dan Golka. He previously served as chief marketing officer at Manhattan Beach-based Playground Entertainment Group Inc., a children’s media and consumer products company, and currently works in sales and business development for International Medical Device Magazine.
“Lawyers are looking for startups; startups are looking for money and lawyers; design companies are looking for [device] companies … People [in the industry] need a place to meet people,” Golka said, adding that the first Med Tech Monday drew about 200 people. He is a one-man team and currently has no revenue.
Golk said MedTech Monday fills that need by discussing topics relevant to startup companies, including cybersecurity and alternative financing options. The one-day conference includes educational seminars and startup presentations.
Proove Biosciences Inc. Chief Executive Brian Meshkin was keynote speaker at the January event. Rachel Branick, deputy district director of Orange County at the U.S. Small Business Administration, also spoke.
Anaheim-based medical technology company Hart Inc. announced it has joined with eVisit Inc. in Mesa, Arizona, to build and integrate eVisit’s telehealth technology onto its core product, HartOS.
“This is not a merger or acquisition but a partnership,” said Hart President Mohammed Alkaday. “We want to partner with people and have them hopping on our platform and building on our [application program interface].
Hart launched its mobile app in 2015 in partnership with St. Joseph Hoag Health. The app is designed to provide healthcare providers and patients better real-time access to medical records, lab results, post-visit instructions, and pill reminders, among others, as well as personal wellness data. The company has added Kiosk, an on-site patient check-in system, and Clarity, which manages physician workflows, to its offerings. Its revenue currently comes only from HartOS. It employs 73.
EVisit develops telemedicine software for healthcare providers.
Allergan PLC completed its $2.9 billion purchase of San Antonio, Texas-based Acelity LP Inc.’s regenerative medicine business unit, LifeCell Corp. The Dublin-chartered pharmaceutical company will add, but not relocate, LifeCell to its Irvine-based aesthetics medicine business, which includes aesthetic and therapeutic Botox, breast implants and derma fillers.